RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: hyperprolactinemia
Accession: DOID:12700
browse the term
Definition: An acquired metabolic disease that has_material_basis_in the presence of abnormally-high levels of prolactin in the blood. (DO)
Synonyms: exact_synonym: HPRL; Hyperprolactinaemia; Inappropriate Prolactin Secretion; Inappropriate Prolactin Secretion Syndrome; hyperprolactinemias; pregnancy-related A-G syndrome; prolactin hypersecretion syndrome
narrow_synonym: FAMILIAL HYPERPROLACTINEMIA
primary_id: MESH:D006966
alt_id: MIM:615555
xref: EFO:0007319 ; ICD10CM:E22.1 ; NCI:C113168
For additional species annotation, visit the
Alliance of Genome Resources .
G
ABCC3
ATP binding cassette subfamily C member 3
ISO
protein:increased expression:liver
RGD
PMID:23486593
RGD:11535162
NCBI chr12:26,920,764...26,978,389
Ensembl chr12:26,920,821...26,979,602
G
DRD2
dopamine receptor D2
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15286066 PMID:19339912 PMID:26297122
RGD:13506955
NCBI chr 9:41,068,618...41,135,262
Ensembl chr 9:41,068,779...41,133,599
G
GAD1
glutamate decarboxylase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7138674
NCBI chr15:76,991,863...77,034,819
Ensembl chr15:76,991,928...77,034,812
G
GDNF
glial cell derived neurotrophic factor
treatment
ISO
RGD
PMID:20219648
RGD:405878070
NCBI chr16:22,936,602...22,965,929
Ensembl chr16:22,936,604...22,966,536
G
GNRH1
gonadotropin releasing hormone 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2204052
NCBI chr14:9,442,971...9,447,521
Ensembl chr14:9,442,971...9,453,035
G
HSD3B1
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
ISO
mRNA:increased expression:ovary (rat)
RGD
PMID:2149342
RGD:4889596
NCBI chr 4:101,565,229...101,574,110
G
LHB
luteinizing hormone subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:6770916
NCBI chr 6:54,263,574...54,269,286
Ensembl chr 6:54,263,576...54,271,086
G
PGR
progesterone receptor
susceptibility
ISO
RGD
PMID:15807882
RGD:1601278
NCBI chr 9:32,035,684...32,129,776
Ensembl chr 9:32,035,684...32,129,221
G
PRL
prolactin
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:serum
CTD RGD
PMID:2880862 PMID:2948424 PMID:4001434 PMID:17303669
RGD:1642575
NCBI chr 7:17,451,367...17,463,771
Ensembl chr 7:17,451,367...17,463,710
G
PRLR
prolactin receptor
ISO
ClinVar Annotator: match by term: Familial hyperprolactinemia
OMIM ClinVar
PMID:25741868 PMID:30575453
NCBI chr16:20,637,568...20,655,881
Ensembl chr16:20,618,875...20,810,140
G
SLC6A3
solute carrier family 6 member 3
treatment
ISO
RGD
PMID:26297122
RGD:13506955
NCBI chr16:79,186,114...79,220,302
Ensembl chr16:79,186,108...79,220,297
G
SRD5A1
steroid 5 alpha-reductase 1
ISO
mRNA:increased expression:prostate (rat)
RGD
PMID:18379994
RGD:4891877
NCBI chr16:75,309,830...75,335,438
Ensembl chr16:75,310,211...75,335,391
G
SRD5A2
steroid 5 alpha-reductase 2
ISO
mRNA:increased expression:prostate (rat)
RGD
PMID:18379994
RGD:4891877
NCBI chr 3:107,840,200...107,918,351
Ensembl chr 3:107,840,200...107,918,350
G
TH
tyrosine hydroxylase
treatment
ISO
protein:increased tyrosine nitration:hypothalamus, median eminence (rat)
RGD
PMID:21178126 PMID:26297122
RGD:13506955 RGD:5128768
NCBI chr 2:1,499,628...1,506,180
Ensembl chr 2:1,499,620...1,506,170
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all